| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |